L.p. Invus, - Net Worth and Insider Trading
L.p. Invus, Net Worth
The estimated net worth of L.p. Invus, is at least $3.0 Billion dollars as of 2024-11-13. L.p. Invus, is the Director, 10% Owner of Blue Buffalo Pet Products Inc and owns about 87,460,875 shares of Blue Buffalo Pet Products Inc (BUFF) stock worth over $3.0 Billion. Details can be seen in L.p. Invus,'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that L.p. Invus, has not made any transactions after 2016-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of L.p. Invus,
L.p. Invus, Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, L.p. Invus, owns 2 companies in total, including Lexicon Pharmaceuticals Inc (LXRX) , and Blue Buffalo Pet Products Inc (BUFF) .
Click here to see the complete history of L.p. Invus,’s form 4 insider trades.
Insider Ownership Summary of L.p. Invus,
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2017-11-10 | director & 10 percent owner |
| BUFF | Blue Buffalo Pet Products Inc | 2018-04-24 | director & 10 percent owner |
L.p. Invus, Latest Holdings Summary
L.p. Invus, currently owns a total of 1 stock. L.p. Invus, owns 87,460,875 shares of Blue Buffalo Pet Products Inc (BUFF) as of September 16, 2016, with a value of $3.0 Billion.
Latest Holdings of L.p. Invus,
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BUFF | Blue Buffalo Pet Products Inc | 2016-09-16 | 87,460,875 | 34.66 | 3,030,956,623 |
Holding Weightings of L.p. Invus,
L.p. Invus, Form 4 Trading Tracker
According to the SEC Form 4 filings, L.p. Invus, has made a total of 0 transactions in Blue Buffalo Pet Products Inc (BUFF) over the past 5 years. The most-recent trade in Blue Buffalo Pet Products Inc is the sale of 12,512,124 shares on September 16, 2016, which brought L.p. Invus, around $311 Million.
Insider Trading History of L.p. Invus,
- 1
L.p. Invus, Trading Performance
L.p. Invus, Ownership Network
Ownership Network List of L.p. Invus,
Ownership Network Relation of L.p. Invus,
L.p. Invus, Owned Company Details
What does Lexicon Pharmaceuticals Inc do?
Who are the key executives at Lexicon Pharmaceuticals Inc?
L.p. Invus, is the director & 10 percent owner of Lexicon Pharmaceuticals Inc. Other key executives at Lexicon Pharmaceuticals Inc include director & President and CEO Lonnel Coats , director & 10 percent owner Raymond Debbane , and SVP & Chief Commercial Officer Thomas Garner .
Lexicon Pharmaceuticals Inc (LXRX) Insider Trades Summary
Over the past 18 months, L.p. Invus, made no insider transaction in Lexicon Pharmaceuticals Inc (LXRX). Other recent insider transactions involving Lexicon Pharmaceuticals Inc (LXRX) include a net purchase of 170,000 shares made by Lonnel Coats , a net purchase of 22,000 shares made by Jeffrey L Wade , and a net purchase of 16,000 shares made by Wendy Mcdermott .
In summary, during the past 3 months, insiders sold 0 shares of Lexicon Pharmaceuticals Inc (LXRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexicon Pharmaceuticals Inc (LXRX) were sold and 29,183,050 shares were bought by its insiders, resulting in a net purchase of 29,183,050 shares.
Lexicon Pharmaceuticals Inc (LXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lexicon Pharmaceuticals Inc Insider Transactions
L.p. Invus, Mailing Address
Above is the net worth, insider trading, and ownership report for L.p. Invus,. You might contact L.p. Invus, via mailing address: C/o The Invus Group, Llc, 750 Lexington Avenue, 30th Floor, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
